Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fortrea Holdings Inc. (FTRE : NSDQ)

• Company Description    Fortrea Holdings Inc. is a provider of clinical development and patient access solutions to the life sciences industry. It provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea Holdings Inc. is based in DURHAM, N.C. Number of Employees: 15,500

• Price / Volume Information    Yesterday's Closing Price: $10.72 Daily Weekly Monthly 20 Day Moving Average: 2,139,694 shares Shares Outstanding: 93.50 (millions) Market Capitalization: $1,002.32 (millions) Beta: 1.81 52 Week High: $18.67 52 Week Low: $3.97 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -36.23% -35.67% 12 Week -24.72% -24.81% Year To Date -37.85% -38.16%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8 MOORE DRIVE - DURHAM,NC 27709 USA ph: 877-495-0816 fax: - investors@fortrea.com http://www.fortrea.com

• General Corporate Information    Officers Anshul Thakral - Chief Executive Officer;President Peter M. Neupert - Chairman of the Board Jill McConnell - Chief Financial Officer Robert Parks - Chief Accounting Officer Edward Pesicka - Director Peer Information Fortrea Holdings Inc. (CORR.) Fortrea Holdings Inc. (RSPI) Fortrea Holdings Inc. (CGXP) Fortrea Holdings Inc. (BGEN) Fortrea Holdings Inc. (GTBP) Fortrea Holdings Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 34965K107 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/11/26 Share - Related Items Shares Outstanding: 93.50 Most Recent Split Date: (:1) Beta: 1.81 Market Capitalization: $1,002.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.13 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.71 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 45.12% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/11/26

• Fundamental Ratios P/E Current FY Estimate: 15.19 Trailing 12 Months: 25.52 PEG Ratio: 0.34 Price Ratios Price/Book: 1.76 Price/Cash Flow: 1.08 Price / Sales: 0.37 EPS Growth vs. Year Ago Period: -50.00% vs. Previous Quarter: -25.00% Sales Growth vs. Year Ago Period: -5.24% vs. Previous Quarter: -5.82% ROE 12/31/25 - 6.23 09/30/25 - 5.64 06/30/25 - 5.25 ROA 12/31/25 - 1.42 09/30/25 - 1.56 06/30/25 - 1.72 Current Ratio 12/31/25 - 0.98 09/30/25 - 1.00 06/30/25 - 1.02 Quick Ratio 12/31/25 - 0.98 09/30/25 - 1.00 06/30/25 - 1.02 Operating Margin 12/31/25 - 1.48 09/30/25 - 1.73 06/30/25 - 2.08 Net Margin 12/31/25 - -36.21 09/30/25 - -36.77 06/30/25 - -37.57 Pre-Tax Margin 12/31/25 - -36.10 09/30/25 - -37.04 06/30/25 - -37.66 Book Value 12/31/25 - 6.10 09/30/25 - 6.40 06/30/25 - 6.51 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - 1.86 09/30/25 - 1.81 06/30/25 - 1.87 Debt-to-Capital 12/31/25 - 65.03 09/30/25 - 64.43 06/30/25 - 65.14

Powered by Zacks Investment Research ©